EdiGene Biotechnology Moves into New R&D Center at Waltham, Mass. to Advance Proprietary LEAPER™ Technology into Transformative in vivo RNA Editing Therapies

BEIJING & WALTHAM, Mass.–(BUSINESS WIRE)–EdiGene, Inc., a global, clinical-stage company focused on translating its gene-editing technologies into transformative genetic medicines for patients with significant unmet medical needs, announced its subsidiary, EdiGene Biotechnology USA, has moved into a new Research & Development Center in Waltham, Mass. to advance proprietary LEAPER™ technology into transformative in vivo RNA … [Read more…]

Global Vitreo Retinal Surgery Devices Pipeline Report 2022 Update: Formulate Significant Competitor Information, Analysis, and Insights to Improve R&D Strategies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. The report enables you to: Formulate significant competitor information, analysis, and insights to improve R&D strategies Identify emerging players with potentially strong product portfolio and … [Read more…]

NextGen Healthcare Kicks Off 25th Annual User Group Meeting with Focus on Enabling Better Healthcare Outcomes for All

Healthcare Professionals Gather for UGM 22, Featuring 125+ Sessions to Learn How to Optimize and Future-Proof Their Practices with Evolving Technologies REMOTE-FIRST COMPANY/NASHVILLE–(BUSINESS WIRE)–$NXGN #NextGenHealthcare–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, has kicked off its 25th annual User Group Meeting (UGM) at the Gaylord Opryland Resort in Nashville. … [Read more…]

Outlook on the Cell & Gene Therapy Clinical Trials Global Market to 2027 – by Phase, Application and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell & Gene Therapy Clinical Trials Market Research Report – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Cell & Gene Therapy Clinical Trials Market size was estimated at USD 5,248.64 million in 2021, USD 5,914.70 million in 2022, and is projected to … [Read more…]

The Worldwide Pupillometer Industry is Expected to Reach $667.5 Million by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pupillometer Market Research Report by Mobility, Type, Application, End-Use, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Pupillometer Market size was estimated at USD 391.23 million in 2021, USD 426.67 million in 2022, and is projected to grow at a CAGR … [Read more…]

Global Hollow Fiber Filtration Market Report 2022: Players Include Asahi Kasei, Cantel Medical, CoorsTek and Danaher – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hollow Fiber Filtration: Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Hollow Fiber Filtration estimated at US$337.8 Million in the year 2020, is projected to reach a revised size of US$809 Million by 2027, growing at a CAGR of 13.3% over the period 2020-2027. Microfiltration, one of … [Read more…]

Outside the US Bayer Extends Development Program for Investigational Product Elinzanetant With Phase III Study in Breast Cancer Patients With Vasomotor Symptoms Caused by Endocrine Therapy

OASIS- 4 plans to investigate elinzanetant as a non-hormonal treatment for vasomotor symptoms caused by endocrine therapy in breast cancer patients Elinzanetant is a non-hormonal compound in development for the treatment of vasomotor symptoms during menopause The OASIS- 4 study is not part of the US development program WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer, a global leader in … [Read more…]

Phil Patient Access Platform Capabilities Support Move to Digital Prescription Models

SAN FRANCISCO–(BUSINESS WIRE)–Today, Phil, Inc., a patient access platform company that revolutionizes life science product commercialization, announced its technology solution now offers expanded functionality for companies developing prescription digital therapeutics (PDTs). Using Phil’s platform, digital health companies can simplify the healthcare journey for patients with their prescription, manage both pharmacy and medical benefits processes and … [Read more…]

Celo Health Delivers HIPAA-Compliant Messaging Platform to Universal Home Care

Celo’s Secure Messaging Solution Provides Immediate Staff Onboarding, Optimized Workflows and Improved Worker Productivity and Satisfaction to Leading Southern California Home Healthcare Provider SEATTLE–(BUSINESS WIRE)–#healthcaremessaging–Celo Health, a leading provider of a HIPAA-compliant messaging platform for healthcare providers, announced today its collaborative messaging solution has delivered immediate staff onboarding, optimized workflows and improved worker productivity and … [Read more…]

Videra Health Uses AI-assisted Video Assessments to Help Signature Healthcare Services Improve Long-term Outcomes for Behavioral Health Patients

OREM, Utah–(BUSINESS WIRE)–Digital health software platform, Videra Health, announced today a partnership with California-based behavioral health system Signature Healthcare Services, to improve patient post-discharge follow-up using AI-assisted video assessments. The partnership combines cutting-edge technology with a trusted, well established behavioral health system. Signature Healthcare Services’ 19 acute care facilities offer a full spectrum of programs … [Read more…]